Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study (EMBONEMET)

Istituto Ortopedico Rizzoli

Status: Enrolling

Conditions: Bone Metastases

Study type: Observational

Funder types: Other

Identifiers

NCT06189079

CE AVEC: 313/2023/Oss/IOR

Details and patient eligibility

About

To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of disease and reduction of peri-operative bleeding, with low invasiveness.

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients of either sex of age or older who are candidates for embolization therapy
• Life expectancy > 3 months
• Single metastatic or oligometastatic.
• Plurimetastatic if a particular site is causing painful symptoms or at risk for pathologic rupture

Exclusion criteria

• Patients with life expectancy <3 months or severe functional status impairment (ASA 4)
• Patients with hypovascular metastasis documented by angiography or MRI perfusion study with MDC.
• Patients with coagulation deficiency or plateletopenic patients.
• Patients with documented active infection.